| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Samuel J Livingston, Eun Jeong Bae, Faride Unda, Michael G Hahn, Shawn D Mansfield, Jonathan E Page, A Lacey Samuel. Cannabis Glandular Trichome Cell Walls Undergo Remodeling to Store Specialized Metabolites. Plant & cell physiology. 2021-08-15. PMID:34392368. |
the valuable cannabinoid and terpenoid metabolites of cannabis sativa l. are produced by floral glandular trichomes. |
2021-08-15 |
2023-08-13 |
Not clear |
| Luigi Bellocchio, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Felice Lorusso, Giuseppina Malcangi, Luigi Santacroce, Antonio Scarano, Ioana Roxana Bordea, Denisa Hazballa, Maria Teresa D'Oria, Ciro Gargiulo Isacco, Ludovica Nucci, Rosario Serpico, Gianluca Martino Tartaglia, Delia Giovanniello, Maria Contaldo, Marco Farronato, Gianna Dipalma, Francesco Inchingol. Cannabinoids Drugs and Oral Health-From Recreational Side-Effects to Medicinal Purposes: A Systematic Review. International journal of molecular sciences. vol 22. issue 15. 2021-08-13. PMID:34361095. |
this review will briefly summarize the components of cannabis and the endocannabinoid system, as well as the cellular and molecular mechanisms of biological cannabis action in human cells and biologic activities on tissues. |
2021-08-13 |
2023-08-13 |
human |
| Luigi Bellocchio, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Felice Lorusso, Giuseppina Malcangi, Luigi Santacroce, Antonio Scarano, Ioana Roxana Bordea, Denisa Hazballa, Maria Teresa D'Oria, Ciro Gargiulo Isacco, Ludovica Nucci, Rosario Serpico, Gianluca Martino Tartaglia, Delia Giovanniello, Maria Contaldo, Marco Farronato, Gianna Dipalma, Francesco Inchingol. Cannabinoids Drugs and Oral Health-From Recreational Side-Effects to Medicinal Purposes: A Systematic Review. International journal of molecular sciences. vol 22. issue 15. 2021-08-13. PMID:34361095. |
we will also look into oropharyngeal tissue expression of cannabinoid receptors, together with a putative association of cannabis to several oral diseases. |
2021-08-13 |
2023-08-13 |
human |
| Erwin Krediet, Debbie Ga Janssen, Eibert R Heerdink, Toine Cg Egberts, Eric Vermette. Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 36. 2021-08-10. PMID:32576481. |
medical cannabis is increasingly used to treat patients with ptsd; however, evidence for the efficacy and safety of cannabinoids is scarce. |
2021-08-10 |
2023-08-13 |
Not clear |
| Eef L Theunissen, Johannes T Reckweg, Nadia R P W Hutten, Kim P C Kuypers, Stefan W Toennes, Merja A Neukamm, Sebastian Halter, Johannes G Ramaeker. Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users. Pharmacology, biochemistry, and behavior. vol 202. 2021-08-10. PMID:33497715. |
intoxication by a synthetic cannabinoid (jwh-018) causes cognitive and psychomotor impairment in recreational cannabis users. |
2021-08-10 |
2023-08-13 |
human |
| Amit Malviya, Shakeel A Khan, Anunay Gupta, Animesh Mishr. Chronic Marijuana Consumption Leading to High-Grade Atrioventricular Block in a Young Male. Cureus. vol 13. issue 7. 2021-08-10. PMID:34367805. |
however, prolonged hv interval and persistent nature of block indicate that direct toxic effects of cannabis, through cannabinoid receptors 1 (cb1r), on the cardiac conduction system cannot be ruled out. |
2021-08-10 |
2023-08-13 |
Not clear |
| Megan C Buckley, Anand Kumar, Arun Swaminat. Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians. Advances in therapy. vol 38. issue 7. 2021-08-05. PMID:34110607. |
additionally, along with the perceived symptom benefits of cannabis come concerning issues like dosing inconsistencies, dependence, and cannabinoid hyperemesis syndrome. |
2021-08-05 |
2023-08-13 |
Not clear |
| Zaid H Maayah, Jason R B Dyc. The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. vol 69. issue 11. 2021-08-04. PMID:32860528. |
given the fact that the administration of cannabis via inhalation is known to rapidly deliver cannabinoids with a higher total bioavailability than what can be achieved through oral or buccal routes, it is important to understand the clinical trials conducted using smoked cannabis on patients with multiple sclerosis. |
2021-08-04 |
2023-08-13 |
Not clear |
| Thomas Heinbockel, Alex Straike. Cannabinoids Regulate Sensory Processing in Early Olfactory and Visual Neural Circuits. Frontiers in neural circuits. vol 15. 2021-08-04. PMID:34305536. |
Δ9-tetrahydrocannabinol (thc) and cannabidiol (cbd) are the main cannabinoids. |
2021-08-04 |
2023-08-13 |
Not clear |
| Thomas Heinbockel, Alex Straike. Cannabinoids Regulate Sensory Processing in Early Olfactory and Visual Neural Circuits. Frontiers in neural circuits. vol 15. 2021-08-04. PMID:34305536. |
thc acts in the brain and nervous system like the chemical substances that our body produces, the endogenous cannabinoids or endocannabinoids, also nicknamed the brain's own cannabis. |
2021-08-04 |
2023-08-13 |
Not clear |
| Atefeh Noori, Anna Miroshnychenko, Yaadwinder Shergill, Vahid Ashoorion, Yasir Rehman, Rachel J Couban, D Norman Buckley, Lehana Thabane, Mohit Bhandari, Gordon H Guyatt, Thomas Agoritsas, Jason W Buss. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. BMJ open. vol 11. issue 7. 2021-08-04. PMID:34321302. |
opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. |
2021-08-04 |
2023-08-13 |
Not clear |
| Christine Mary Hallinan, Edward Eden, Myfanwy Graham, Lisa-Marie Greenwood, Jessica Mills, Amirali Popat, Linda Truong, Yvonne Bonom. Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group. Journal of psychopharmacology (Oxford, England). 2021-08-04. PMID:34344208. |
amidst growing global acceptance of medicinal cannabinoids as a potential therapeutic interest in cannabidiol (cbd) is increasing. |
2021-08-04 |
2023-08-13 |
Not clear |
| R Andrew Moore, Emma Fisher, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804833. |
cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. |
2021-08-03 |
2023-08-13 |
human |
| R Andrew Moore, Emma Fisher, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804833. |
cannabinoids, cannabis, and cannabis-based medicines (cbm) are increasingly used to manage pain, with limited understanding of their efficacy and safety. |
2021-08-03 |
2023-08-13 |
human |
| R Andrew Moore, Emma Fisher, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804833. |
they included any type of cannabinoid, cannabis, or cbm, at any dose, however administered, in a broad range of pain conditions. |
2021-08-03 |
2023-08-13 |
human |
| R Andrew Moore, Emma Fisher, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804833. |
systematic reviews with positive or negative recommendation for use of cannabinoids, cannabis, or cbm in pain typically rated critically low or low (24/25 [96%] positive; 10/12 [83%] negative). |
2021-08-03 |
2023-08-13 |
human |
| R Andrew Moore, Emma Fisher, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804833. |
a new high-quality systematic review of randomised controlled trials is needed to critically assess the clinical evidence for cannabinoids, cannabis, or cbm in pain. |
2021-08-03 |
2023-08-13 |
human |
| Emma Fisher, R Andrew Moore, Alexandra E Fogarty, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804836. |
cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. |
2021-08-03 |
2023-08-13 |
human |
| Emma Fisher, R Andrew Moore, Alexandra E Fogarty, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804836. |
cannabinoids, cannabis, and cannabis-based medicines (cbms) are increasingly used to manage pain, with limited understanding of their efficacy and safety. |
2021-08-03 |
2023-08-13 |
human |
| Emma Fisher, R Andrew Moore, Alexandra E Fogarty, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804836. |
we included 36 studies (7217 participants) delivering cannabinoids (8 studies), cannabis (6 studies), and cbm (22 studies); all had high and/or uncertain risk of bias. |
2021-08-03 |
2023-08-13 |
human |